Phase II trial of irinotecan, paclitaxel and carboplatin in patients with previously untreated Stage IIIB/IV nonsmall cell lung carcinoma - Concepedia

Concepedia

Publication | Closed Access

Phase II trial of irinotecan, paclitaxel and carboplatin in patients with previously untreated Stage IIIB/IV nonsmall cell lung carcinoma

20

Citations

35

References

2002

Year

Mark A. Socinski, Alan B. Sandler, Valerie K. Israel, Heidi H. Gillenwater, Langdon L. Miller, Paula K. Locker, A Antonellini, Gary Elfring, Ronald B. Natale

Abstract

The combination of CPT-11, paclitaxel, and carboplatin can be safely administered and is active in the treatment of advanced NSCLC. Based on the favorable survival outcome, this regimen is undergoing evaluation in prospective randomized trials.

References

	Year	Citations

Page 1